Clinical Trial

Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma

Name: Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma — clinical trial record (NCT07585032)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: EUSRFAINSU

Recruiting

View on ClinicalTrials.gov →

Summary

Transcutaneous and EUS-guided radiofrequency ablation are both modern modalities to apply in the managemnet of various malignancies. In the current study the investigators aim to study the technical feasibility, patient safety and clinical efficacy of EUS-RFA for the treatment of pancreatic insulinoma.

Trial Details

NCT Number	NCT07585032
Lead Sponsor	Sahlgrenska University Hospital
Conditions	Insulinoma; Pancreas
Enrollment	20 participants
Start Date	2025-03-31
Primary Completion	2028-12 (estimated)
Study Completion	2029-06 (estimated)
Updated on ClinicalTrials.gov	2026-05-13